Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
S. Palacios, M. Ramirez & M. Lilue. (2022) Efficacy of low-dose vaginal 17β-estradiol versus vaginal promestriene for vulvovaginal atrophy. Climacteric 25:4, pages 383-387.
Read now
Read now
C. Rueda, A. M. Osorio, A. C. Avellaneda, C. E. Pinzón & O. I. Restrepo. (2017) The efficacy and safety of estriol to treat vulvovaginal atrophy in postmenopausal women: a systematic literature review. Climacteric 20:4, pages 321-330.
Read now
Read now
R. J. Santen. (2015) Vaginal administration of estradiol: effects of dose, preparation and timing on plasma estradiol levels. Climacteric 18:2, pages 121-134.
Read now
Read now
Luciano Mariani, Angiolo Gadducci, Enrico Vizza, Silverio Tomao & Patrizia Vici. (2013) Vaginal atrophy in breast cancer survivors: role of vaginal estrogen therapy. Gynecological Endocrinology 29:1, pages 25-29.
Read now
Read now
Nicoletta Biglia, Elisa Peano, Paola Sgandurra, Giulia Moggio, Enrico Panuccio, Marco Migliardi, Nicoletta Ravarino, Riccardo Ponzone & Piero Sismondi. (2010) Low-dose vaginal estrogens or vaginal moisturizer in breast cancer survivors with urogenital atrophy: a preliminary study. Gynecological Endocrinology 26:6, pages 404-412.
Read now
Read now
R. E. Nappi, F. Albani, L. Chiovato & F. Polatti. (2009) Local estrogens for quality of life and sexuality in postmenopausal women with cardiovascular disease. Climacteric 12:sup1, pages 112-116.
Read now
Read now
O. Al-Baghdadi & A. A. A. Ewies. (2009) Topical estrogen therapy in the management of postmenopausal vaginal atrophy: an up-to-date overview. Climacteric 12:2, pages 91-105.
Read now
Read now
H Kuhl. (2005) Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric 8:sup1, pages 3-63.
Read now
Read now